Story Protocol’s IP token has seen a sharp 15% bounce, trading just above $3 after days of downward drift. The surge was accompanied by a sudden 118% spike in trading volume and large-scale whale accumulation, fueling speculation around the project’s…Story Protocol’s IP token has seen a sharp 15% bounce, trading just above $3 after days of downward drift. The surge was accompanied by a sudden 118% spike in trading volume and large-scale whale accumulation, fueling speculation around the project’s…

Story Protocol jumps 15% as whales buy $47M in tokens, platform teases upcoming ‘Big things’

3 min read

Story Protocol’s IP token has seen a sharp 15% bounce, trading just above $3 after days of downward drift.

The surge was accompanied by a sudden 118% spike in trading volume and large-scale whale accumulation, fueling speculation around the project’s next major move. Blockchain data flagged by Lookonchain on June 23 shows two major wallets collectively purchased 16 million Story Protocol (IP) tokens, worth nearly $47.5 million. 

One address acquired 6 million tokens, while another scooped up 10 million. The timing is notable, arriving just as market-wide sentiment steadied following Bitcoin’s (BTC) recovery back above the $100,000 level after slipping on geopolitical fears tied to U.S. strikes in Iran.

Despite the gain, IP is still down around 30% over the month and 16% in the past week. However, the fresh accumulation echoes a pattern seen earlier this year. Back then, significant whale inflows were followed by a 40% price rally. 

Whether history repeats depends, in part, on what the Story Protocol team has in store. A brief post on the project’s social media channels teased that “big things” are coming, without offering details.

So far in 2025, Story Protocol has seen steady infrastructure progress. February’s Homer mainnet launch processed millions of IP registrations. March brought a public preview of the IP Portal, which enables creators to register and browse tokenized intellectual property. 

The protocol also partnered with Oxford University to advance AI-agent frameworks, expanded liquidity through Orderly Network, and closed an $80 million Series B led by a16z. More than 100 projects have been onboarded so far, including well-known ones like Stanford and StabilityAI.

Looking at the technical picture, the price action is showing signs of a recovery, but it is still fragile. Across all timeframes, the token continues to trade below important moving averages. Both the 10-day and 20-day estimated moving averages are above current levels, at $3.09 and $3.40 respectively, indicating downward pressure.

Story Protocol jumps 15% as whales buy $47M in tokens, platform teases upcoming 'Big things' - 1

An imminent breakout is indicated by the Bollinger Bands’ compression. Indicators are still not entirely consistent. The MACD and awesome oscillator are still in negative territory, and the relative strength index is close to oversold territory, at about 38. Even though momentum has recently flipped into a buy signal, volume trends do not offer compelling confirmation,

If bulls can regain the $3.30–$3.50 range, there may be a recovery toward $4. On the downside, if $3 is not held, the asset might drop to $2.70 or $2.50, especially if Bitcoin struggles again. For the time being, sentiment is dependent on whether Story Protocol’s next action justifies the optimism and on follow-through whale action.

Market Opportunity
TokenFi Logo
TokenFi Price(TOKEN)
$0.00364
$0.00364$0.00364
-1.86%
USD
TokenFi (TOKEN) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

The surge follows a difficult August, when investors pulled out more than $750 million while rotating capital into Ethereum-focused funds. […] The post Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge appeared first on Coindoo.
Share
Coindoo2025/09/18 01:15
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29